News ( Year: 2020 )

SORT BY YEAR
16 March, 2020

Ally Bridge Portfolio News – WuXi Biologics and Vir Biotechnology Announce Collaboration for Global Development of Antibodies to Treat COVID-19

SAN FRANCISCO and SHANGHAI, Feb. 25, 2020 /PRNewswire/ — WuXi Biologics (“WuXi Bio”) (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, and Vir Biotechnology, Inc. (“Vir”) (Nasdaq: VIR) today announced a development and manufacturing collaboration to advance and produce human monoclonal antibodies for the potential treatment of Coronavirus Disease 2019 (COVID-19), a […]

Read More
21 February, 2020

Ally Bridge Group leads $30 mln investment in Israel’s Mavrik Dental

JERUSALEM, Feb 18 (Reuters) – Israel’s Mavrik Dental Systems has raised $30 million in a funding round led by life sciences investment firm Ally Bridge Group (ABG), the companies said on Tuesday. Mavrik provides technologies for in-office dental treatment. Following ABG’s investment, Mavrik will move commercial operations to the United States while keeping its product […]

Read More
19 February, 2020

Ally Bridge Group Leads US$70 million Investments in Two Israeli Life Science Companies over the Last 2 Months

TEL AVIV, Israel, HONG KONG and NEW YORK, Feb. 18, 2020 /PRNewswire/ — Ally Bridge Group (“ABG”), a leading global life science investment group, has announced that it recently led US$70 million investments in two Israeli life sciencecompanies over the last 2 months. Each of the two companies is a commercial-stage, leading innovator re-setting the standard of care in its respective area. They include: […]

Read More